UK Court Blocks Edwards’ TAVR Device For Patent Infringement
Edwards’ Pascal transcatheter mitral valve repair devices has been blocked from most use after being found to infringe on Abbott’s patents by a British court.
You may also be interested in...
Edwards Lifesciences is paying Abbott Laboratories to settle disputes over patents on transcatheter mitral and tricuspid repair products.
Edwards Lifesciences received the CE mark for its PASCAL transcatheter system for treating triscupid valve regurgitation, competing against Abbott’s newly CE-marked TriClip.
The US Patent Office has rejected a request by Edwards Lifesciences to review an Abbott patent on heart-valve technology, which could establish the patent as a key part of Abbott Laboratories’ arguments in a larger ongoing intellectual property case.